Last edition
News about "AbbVie, Amgen, AstraZeneca, Bayer, Bristol Myers S"
Alnylam Pharmaceuticals Joins Alliance for Genomic Discovery to Advance RNAi Therapeutics
Alnylam Pharmaceuticals has become the ninth member of the Alliance for Genomic Discovery (AGD), joining AbbVie, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, GSK, Merck, and Novo Nordisk.
AbbVie, Amgen, AstraZeneca, Bayer, Bristol Myers S | 19/09/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members